# A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

> **NCT00002330** · NA · COMPLETED · sponsor: **Roche Global Development** · enrollment: 280 (—)

## Conditions studied

- Cytomegalovirus Retinitis
- HIV Infections

## Interventions

- **DRUG:** Ganciclovir

## Key facts

- **NCT ID:** NCT00002330
- **Lead sponsor:** Roche Global Development
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 280 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002330, "A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00002330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*